openPR Logo
Press release

Leiden University Medical Center Chooses Martello to Improve the Performance and Reliability of Hybrid Cloud-Based Services

06-11-2019 10:04 AM CET | IT, New Media & Software

Press release from: Martello Technologies

Ottawa, Canada (June 7, 2019) – Martello Technologies Group Inc., (“Martello” or the “Company”), a leading provider of solutions that deliver clarity and control of complex IT environments, announced today that Leiden University Medical Center (LUMC) has chosen Martello’s iQ IT visualization software for better control and insight into the performance of hybrid cloud-based services, with a single pane of glass consolidating performance data from multiple sources.
Cloud computing has changed the way applications and services are delivered and has transformed many businesses from private to hybrid cloud environments. Datacenters and networks are no longer easily controlled, and it can be challenging to deliver reliable service quality in hybrid cloud environments that mix public and private components. Martello is helping organizations like LUMC solve this problem. The Company’s iQ IT visualization software integrates with the industry’s most common IT monitoring and service management tools, as well as cloud-based services like Microsoft Office 365 and Azure, to deliver a range of performance data and analytics from a single dashboard.
Leiden University Medical Center, located in Leiden, Netherlands, is the university hospital affiliated with Leiden University. “Leiden University Medical Center has depended on Martello’s solutions to deliver insight and reliability for our mission-critical IT infrastructure for close to ten years. Over this period, Martello’s solutions have grown with us and helped us manage our hybrid cloud environment more effectively,” said Willem Bouwman, IT Specialist, SQL Database and SCOM Monitoring in the Information Technology and Digital Innovation department of Leiden University Medical Center. “Most recently, we’ve again expanded our relationship with Martello to gain better control of our Office 365 service delivery.”
LUMC has integrated several IT monitoring and management tools into its iQ dashboard, including SCOM, TOPDesk, SolarWinds and Zabbix, and recently brought its Microsoft Office 365 deployment onto this system, for a single view of all relevant performance data in its IT hybrid cloud infrastructure.
“Leiden University Medical Center is both innovative and proactive when it comes to managing its IT infrastructure, a critical asset for the organization,” said Stefanie Richheimer, Chief Revenue Officer of Martello Technologies. “Never satisfied with the status quo, LUMC is always looking to improve service delivery for its users, and we’re pleased to work with them to provide solutions.”
Martello’s solutions have been widely acclaimed in the industry. In September 2018, Martello received a Frost & Sullivan Leadership Award for NPM (Network Performance Management) and ranked as Ottawa’s Fastest Growing Company, at No. 28 on the Growth 500 list of Canada’s Fastest Growing Companies. The Company has expanded its solution portfolio with several acquisitions, and recently provided a business update on its market and channel expansion, product innovation, acquisitions and capital market activities.
About Martello Technologies Group
Martello Technologies Group Inc. (TSXV: MTLO) is a technology company that provides clarity and control of complex IT infrastructures. The company develops products and solutions that monitor, manage and optimize the performance of real-time applications on networks, while giving IT teams and service providers control and visibility of their entire IT infrastructure. Martello’s products include SD-WAN technology, network performance management software, and IT analytics software. Martello Technologies Group is a public company headquartered in Ottawa, Canada with offices in Montreal, Amsterdam, Paris, Dallas and New York. Learn more at http://www.martellotech.com

-end-

FORWARD LOOKING STATEMENTS: This press release contains forward-looking statements that address future events and conditions, which are subject to various risks and uncertainties. Actual results could differ materially from those anticipated in such forward-looking statements as a result of numerous factors, some of which may be beyond the Corporation's control. These factors include: general market and industry conditions, risks related to continuous operations and to commercialization of new technologies and other risks disclosed in the Corporation's filings with Canadian Securities Regulators.

Forward-looking statements are based on the expectations and opinions of the Corporation's management on the date the statements are made. The assumptions used in the preparation of such statements, although considered reasonable at the time of preparation, may prove to be imprecise and, as such, undue reliance should not be placed on forward-looking statements. The Corporation expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

CONTACTS:
Tracy King
VP Marketing
tking@martellotech.com
613.271.5989 x 2112

Laurenn Wolpoff
MRB Public Relations
(on behalf of Martello)
732.758.1100 x. 101
lwolpoff@mrb-pr.com

390 March Road Suite #110
Kanata, ON K2K OG7

Martello Technologies Group Inc. (TSXV: MTLO) is a technology company that provides clarity and control of complex IT infrastructures. The company develops products and solutions that monitor, manage and optimize the performance of real-time applications on networks, while giving IT teams and service providers control and visibility of their entire IT infrastructure. Martello’s products include SD-WAN technology, network performance management software, and IT analytics software. Martello Technologies Group is a public company headquartered in Ottawa, Canada with offices in Montreal, Amsterdam, Paris, Dallas and New York. Learn more at http://www.martellotech.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Leiden University Medical Center Chooses Martello to Improve the Performance and Reliability of Hybrid Cloud-Based Services here

News-ID: 1770073 • Views:

More Releases from Martello Technologies

Martello Partners with Suria to Power Network Performance in Malaysia
Malaysian partner helps businesses improve the performance of real-time services and enable IoT with Martello SD-WAN, IT Ops visualization and performance management solutions. Ottawa, Canada (July 3, 2019) – Martello Technologies Group Inc., (“Martello” or the “Company”) (TSXV: MTLO), a leading provider of solutions that deliver clarity and control of complex IT environments, today announced a partnership with Suria Business Solutions, a provider of IP Telephony and Unified Communications & Collaboration
Martello Grows in the Middle East Hospitality Industry with Naizak Distribution
Partnership has led to more than 50 hotel clients in the region, as the number of five star luxury properties grow in Dubai. Ottawa, Canada (June 11, 2019) – Martello Technologies Group Inc., (“Martello” or the “Company”) (TSXV: MTLO), a leading provider of solutions that deliver clarity and control of complex IT environments, provided an update today on customer activity in the hospitality industry in the Middle East, driven by its
Martello Showcases Network Performance Solution for Mobile IoT Applications with …
Ottawa, Canada (May 31, 2019) – Martello Technologies Group Inc., (“Martello” or the “Company”), a leading provider of solutions that deliver clarity and control of complex IT environments, announced today to mark National Autonomous Vehicle Day, the demonstration of a network performance management solution for mobile applications such as autonomous vehicles. The proof of concept was developed in collaboration with BlackBerry QNX as part of the BlackBerry QNX/L-Spark Accelerator, and
Frost Bank Chooses Martello for Better Control of IT Environment
Martello Technologies Group Inc. (“Martello”) (TSXV: MTLO), a leading provider of network performance management solutions for real-time communications, announced today that Frost Bank, a Texas-based chartered bank that is among the largest banks in the United States, has chosen to renew its contract for the Savision IT operations management software products for the next three years. This follows an eight year relationship in which Frost Bank has continually expanded its

All 5 Releases


More Releases for Leiden

Motorcycle Helmet Visor market: New Prospects to Emerge by 2028 | WeeTect, Leide …
" The Motorcycle Helmet Visor global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key
Factor V Leiden Thrombophilia Treatment Market 2021 Revealing Top Trends, Growth …
Factor V Leiden Thrombophilia Treatment Market - Overview Factor V Leiden thrombophilia is a genetic disease that improves the probability of developing blood coagulation sooner or later throughout everyday life. At the point when a coagulation structures, it normally occurs in the legs, known as deep venous thrombosis (DVT) or the lungs known as pulmonary embolism (PE). The name Factor V Leiden alludes to a particular quality transformation in the F5
Factor V Leiden Thrombophilia Treatment Market Scope, Segmentation, Development …
Factor V Leiden Thrombophilia Treatment Market - Overview Factor V Leiden thrombophilia is a genetic disease that improves the probability of developing blood coagulation sooner or later throughout everyday life. At the point when a coagulation structures, it normally occurs in the legs, known as deep venous thrombosis (DVT) or the lungs known as pulmonary embolism (PE). The name Factor V Leiden alludes to a particular quality transformation in the F5
Global Dilution Refrigerators Market Production, Revenue, Demand, Supplier, Lead …
This research report titled “Global Dilution Refrigerators Market Insights, Forecast to 2025” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Dilution Refrigerators Market during the period between 2019 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to
Industrial Vacuum Cleaners Market Detailed Report With Growth Opportunity by Maj …
Up Market Research published a detailed report on “Global Industrial Vacuum Cleaners Market Size Status and Forecast 2026”. The report provides an in-depth overview of industry and competitive landscape, covering multiple market segments and elaborates market outlook and status to 2026. Get Sample Copy Of This Report @ https://www.upmarketresearch.com/home/requested_sample/86547 The report contains pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and
Factor V leiden and prothrombin G20210A mutations may predispose for cerebral in …
A recent age- and sex-matched paired case-control study comparing patients suffering from cerebral infarction with and without patent foramen ovale (PFO) revealed that the occurence of factor V leiden and, to a lesser extent, of prothrombin G20210 A mutation is a clinically relevant risk for the development of cerebral infarction in association with PFO. Berhard Stephan and his team at the University Hospitals of Saarland, Homburg (Germany) studied a total of